Jopp H, Kraft A, Hoffmann B, Merkel R, et al. Preclinical validation of PKC412 as a therapy candidate for epidermolysis bullosa simplex across multiple keratin pathogenic variants. Br J Dermatol 2025;193:741-757.
PMID: 40406951